Immunophenotypes associated with bipolar disorder and lithium treatment
نویسندگان
چکیده
منابع مشابه
Lithium treatment for bipolar disorder.
This section looks back to some of the ground-breaking contributions to public health, reproducing them in their original form and adding a commentary on their significance from a modern-day perspective. To complement this month’s theme of the Bulletin, Philip B. Mitchell and Dusan Hadzi-Pavlovic review the 1949 paper by John F.J. Cade on the use of lithium salts in the treatment of psychotic e...
متن کاملLong term use of lithium and factors associated with treatment response among patients with bipolar disorder.
BACKGROUND Lithium has been the gold standard in treating bipolar disorder. In recent years, the use of lithium seems to be diminished although it is well tolerated among the bipolar disorder patients. SUBJECTS AND METHODS This study aimed to evaluate the efficacy and tolerability of lithium as well as to determine factors associated with lithium response among patient with bipolar disorder. ...
متن کاملOutcome of bipolar disorder on long-term treatment with lithium.
The long-term treatment outcome of 248 bipolar patients in an out-patient lithium programme was assessed. Over half of the patients (138 or 56%) had no affective episodes in the year observed. Patients were divided into outcome groups according to GAS scores: the outcome for 40% of patients was good, for 41% fair, and for 19% poor. More frequent psychiatric admissions before starting lithium tr...
متن کاملBipolar disorder associated with interferon-alpha treatment.
Accepted 9 July 1997 Interferon-alpha (Hoffman-La Roche Ltd, Basel, Switzerland) is a highly purified, bacterially synthesized agent with antiviral, antiproliferative and immunomodulatory properties.' Interferon-alpha has been approved for the treatment of several types of cancer (eg, leukaemia, lymphoma, renal cell carcinoma and melanoma) and of chronic hepatitis.2'4 Usually causing flu-like s...
متن کاملGenetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study
BACKGROUND Lithium is a first-line treatment in bipolar disorder, but individual response is variable. Previous studies have suggested that lithium response is a heritable trait. However, no genetic markers of treatment response have been reproducibly identified. METHODS Here, we report the results of a genome-wide association study of lithium response in 2563 patients collected by 22 partici...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scientific Reports
سال: 2019
ISSN: 2045-2322
DOI: 10.1038/s41598-019-53745-7